Recent human genetic studies suggest that cells of the innate immune system have a primary role in the pathogenesis of neurodegenerative diseases. However, the results from these studies often do not elucidate how the genetic variants affect the biology of these cells to modulate disease risk. Here, we applied a tensor decomposition method to uncover disease-associated gene networks linked to distal genetic variation in stimulated human monocytes and macrophages gene expression profiles. We report robust evidence that some disease-associated genetic variants affect the expression of multiple genes in trans. These include a Parkinson's disease locus influencing the expression of genes mediated by a protease that controls lysosomal function, and Alzheimer's disease loci influencing the expression of genes involved in type 1 interferon signaling, myeloid phagocytosis, and complement cascade pathways. Overall, we uncover gene networks in induced innate immune cells linked to disease-associated genetic variants, which may help elucidate the underlying biology of disease.
Introduction
Genome-wide associated studies (GWAS) have identified tens of thousands of common genetic variants associated with complex traits and diseases 1, 2 . The vast majority of these genetic variants reside in non-coding regions 3 potentially affecting the regulation of gene expression of local (cis) or distal (trans) genes. An extensive number of studies have characterized expression Quantitative Trait Loci (eQTL) across multiple tissues [4] [5] [6] and cell types [7] [8] [9] [10] and in response to environmental stimuli 11, 12 . Nevertheless, most eQTL studies in humans have been limited almost exclusively to cis-effects. The few studies that have investigated trans-eQTLs have identified few significant associations, and there has been little replication of significant associations across data sets. One limitation is that most of these studies used complex mixtures of different cell types (e.g., brain tissue, whole blood or peripheral blood mononuclear cells [PBMCs]) as RNA sources 13 , which may result in the failure to properly capture the activity of genetic variants in disease-relevant cell types. Another limitation is that these studies report trans-eQTLs by performing millions of Single Nucleotide Polymorphism (SNP)-bygene tests, which can result in few significant associations due to the very stringent significance threshold imposed by multiple testing burden correction. Such SNP-by-gene trans-eQTL mapping also ignores the complex structure of gene networks. Recently, Hore, et al. 14 developed a method to decompose a tensor (or multi-dimensional array) of multi-tissue gene expression data to uncover gene networks and map these networks with genetic variants to detect trans-eQTLs. This and similar methods [15] [16] [17] have been successful in mapping networks of genes regulated by genetic variants that would not have been uncovered via marginal SNP-by-gene trans-eQTL analysis.
Discovering such trans-eQTL networks may improve our understanding of the biological mechanisms underlying polygenic diseases such as Alzheimer's disease and Parkinson's disease. Both are neurodegenerative diseases which share pathological hallmarks such as neuronal loss, proteinopathy, mitochondrial dysfunction and reactive microglia (the innate immune cells of the brain) 18, 19 , although the specific vulnerable cells differ between disorders. GWAS have identified over 30 and 41 loci, respectively, associated with Alzheimer's disease 20, 21 and Parkinson's disease 22 . Nevertheless, these studies open new questions as they identify SNPs rather than genes, most of them localized in non-coding regions that are thought to modulate disease risk by influencing the expression of nearby or distal genes in a cell-type specific manner. Therefore, translating the effect of risk alleles to the genes and cell types involved in disease pathogenesis remain a challenge. Along this line, it should be noted that analyses of the human genetic data point to enrichment of Alzheimer's disease and Parkinson's disease risk alleles in genes, epigenetic annotations and cis-eQTL effects associated with myeloid cells of the innate immune system 7, 23 . Animal models have also pointed to an altered innate immune system as a potential driver of these diseases [24] [25] [26] . While most research has focused on the contribution of microglia in neurodegeneration, there are reports suggesting a causal role of cellular and humoral components of the peripheral innate immune system in the pathogenesis and progression of these diseases. For example, parabiosis studies suggest that peripheral blood components may influence Alzheimer's disease progression 27 . Whether peripheral blood monocytes may themselves be drivers of disease or are simply useful proxies for the infiltrating macrophages and/or resident microglia found at the sites of neuropathology is still unknown. We hypothesize that AD and PD risk alleles may modulate disease susceptibility by regulating the expression of a distal gene or set of genes in monocytes and macrophages (major cellular components of the innate immune system).
Here we used gene expression profiles from monocytes to identify novel trans-eQTLs and replicate those previously known. We show that about one-third of trans regulation is significantly mediated by the expression of cis genes. We identified trans-eQTLs that colocalize with disease-associated susceptibility loci. These include GWAS loci for coronary artery disease, body mass index, and cholesterol, all traits for which peripheral blood monocytes and macrophages are functionally relevant. More interestingly, our analysis also discovered biologically meaningful trans-eQTL networks for neurodegenerative diseases including genes in interferon and complement signaling, as well as lysosomal function linked to Alzheimer's and Parkinson's disease susceptibility loci, respectively. These results highlight context-specific trans-eQTL networks in support of a role for myeloid cells of the innate immune system as key modifiers of neurodegenerative disease risk.
Results

Identification of gene networks in stimulated monocytes and macrophages
We used Sparse Decomposition of Arrays (SDA) 14 to construct gene networks by decomposing a multi-array set of gene expression measurements into latent components (see Methods). Each of these components consists of scores that indicate the relative contribution of each individual, gene, and cell or stimulation activity scores to gene networks (Fig. 1) . The individual scores are the magnitude of the effect for each component across individuals. We use the individual scores as phenotypes in genome-wide trans-eQTL analysis to identify common genetic variants that drive each component. The gene scores (or gene loadings) allow to infer more clearly which genes are involved in each component. SDA is developed in a Bayesian framework and use 'spike and slab' prior 28 to allow gene scores of each component to have unique level of sparsity. Finally, the cell or stimulation specificity scores indicate the activity of the component for each inflammatory stimuli or cell types. (A) The gene expression datasets used in this study. Stimulated monocyte gene expression profiles from Fairfax, et al. 12 in four conditions: response to lipopolysaccharide at 24 hours (LPS24) and at 2 hours (LPS2), interferon-γ (IFN-γ), and naive (left panel). Peripheral blood monocytes (MP) and macrophages (MC) from the Cardiogenics Consortium 14 . An illustration of decomposition of gene expression datasets to yield component vectors for relative contribution of each individual, gene and condition. The individual scores matrices are then used as phenotypes with SNP genotypes in order to identify genetic variation correlated with the components (top). The stimulation or cell-activity scores matrix is used to identify the contribution of each condition for the components (middle). The gene scores matrix is used to identify the contribution of each gene within the components (bottom).
We used gene expression profiles from two previously published studies: (1) Fairfax et al. 12 (FF), in which CD14 + human monocytes were profiled with two inflammatory stimuli: naïve (CD14), and in response to either interferon-γ (IFN), to lipopolysaccharide at 2 hours (LPS2), or at 24 hours (LPS24); and (2) primary human monocytes and macrophages from the Cardiogenics Consortium (CG) 29 , which includes subjects from a Cardiovascular disease cohort (Fig. 1) . The IFN-γ and LPS stimuli were used to elicit an immune reactive phenotype in these cells that may help detect gene networks unidentifiable in the naïve state and better approximate the state of these cells in the context of a degenerating brain. On the other hand, the monocytes and macrophages comparison may help uncover different pathogenic effects of these two cell types. We computed a maximum of 500 components in each dataset, of which the majority were non-sparse (most genes with low or zero gene scores). These non-sparse components capture technical or biological confounders in the expression data ( Fig. 2A and Supplemental Fig. S1 ). Using a ranked-based sparsity statistic (see Methods), we identified 56 and 111 components in FF and CG, respectively, that are sparse, or components with distinguishable non-zero and high scoring genes (Supplemental Tables S1 and S2). In the FF dataset we identified 12 sparse components active in naïve, 5-9 105  121  140  152  170  180  201  202  215  22  222  26  28  281  307  317  319  34  343  353  363  371  392  403  419  421  439  451  477  52  61  73  82  84 
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active in response to IFN-γ, LPS 2hrs, or LPS 24hrs, and the remaining 25 shared across all conditions ( Fig.  2B) . In CG, 42 sparse components were specific to monocytes and 45 specific to macrophages and 24 were shared between the two cell types (Supplemental Fig. S1 ). Using a two-way reverse correlation approach, we found 7 of the 56 sparse components in FF are conserved between FF and CG ( Supplemental Table S3 ). An example of a shared component is shown in Figure 2C .
To assess the functional significance of the components, we tested the genes within each component for enrichment in Gene Ontology (GO) biological processes. We found significant enrichment for GO biological processes for 30 out of 56 sparse components, suggesting that the genes in each sparse component are part of coherent biological processes ( Supplemental Table S4 ). To assess the enrichment of disease risk loci in these components, GWAS summary statistics from 18 selected traits and gene-sets from the sparse components were used as input for MAGMA 30 . We found three components significantly enriched for genes in GWAS loci at a Bonferroni-corrected significance threshold and additional four components enriched at a nominal P-value < 0.05 for ten traits ( Supplemental Table S5 ). This includes a component with genes in the interferon-signaling pathway, which is enriched for genes in Alzheimer's disease susceptibility loci. Overall, these results suggest that the sparse components from stimulated monocyte gene expression data have functional significance and, in some cases, may underlie disease-relevant biological processes.
We next reasoned that the monocyte components might contain genes in disease-associated loci that disproportionately contribute to the heritability of complex diseases. We used LD score regression (LDSC) 31 to partition GWAS heritability into the contribution of SNPs located within genes form each component. We found that 36 out of 56 sparse components in FF showed significant enrichment (FDR-corrected P < 0.05) for 18 different traits. This includes a component in FF data (component 61) with significantly enriched for SNP-based heritability for seven traits including Alzheimer's (7.6-fold, P < 0.03), Parkinson's (13-fold, P < 0.01) as well as number of inflammatory and metabolic diseases ( Fig. 2D ; Supplemental Table S6 ). Another component that is significantly enriched for SNP-based heritability for Alzheimer's disease (16.4-fold, P < 0.04), autism (5.1fold, P < 0.03), and lupus (5.7-fold P < 0.03), accounting for 6%, 2% and 2% of SNP-based heritability, respectively. Component 22 is highly enriched for a number of genes in the Type 1 interferon-signaling, defense response to virus, and complement activation pathways ( Figure 2E ). A number of studies have linked genes from these functional categories to Alzheimer's disease, autism 32, 33 and lupus 13 . Interestingly, we discovered that this component is also a trans-eQTL for Alzheimer's disease susceptibility loci (see below). Taken together, these results illustrate that several components identified in this study can explain substantial amount of SNP-based genetic heritability for many common diseases and begin to implicate specific innate immune function for common variants across neurodegenerative and inflammatory diseases.
Detection of context-specific trans-eQTLs
To detect trans-eQTLs, the individual scores from each component are tested for association with genotype dosages (autosomal SNPs, Minor Allele Frequency [MAF] > 0.01, imputed with the Haplotype Reference Consortium reference panel) across the genome. A stringent quality control (QC) procedure was used to filter out multi-mapped gene probes and non-coding genes prior to trans-eQTL analysis (Methods). For clarification, hereinafter, we define the following: a trans-eQTL to be an SNP that maps to a component, the relevant SNP itself to be the trans-eSNP and any genes within the component to be trans-eGene(s). In FF, we identified a total of 15,856 trans-eQTLs (FDR < 0.05) representing 15,298 unique SNPs (833 independent SNPs; obtained by pruning SNPs in LD with r 2 < 0.2) and 55 unique sparse components ( Supplemental Table S7 ). Of the significant trans-eQTLs, approximately 55% are stimuli-specific, detected only in response to either IFN-γ or LPS challenge. For CG, we identified a total of a total of 3,945 trans-eQTLs (FDR < 0.05) representing 3,217 unique SNPs (70 independent SNPs; obtained by pruning SNPs in LD with r 2 < 0.2) and 57 unique sparse components ( Supplementary Table S8 ). In each dataset, the components contain anywhere between 5-62 genes with distinguishable non-zero gene scores based on distributional cut-offs (Methods). Our analysis confirmed previously published trans-eQTL: a cis-eQTL at rs2275888 for IFNB1 is associated with the expression of 17 genes in trans after 24-hour LPS stimulation, many of which are interferon (IFN-β) response genes 2 (Supplementary Fig. S2 ).
Trans-eQTLs in stimulated monocytes as putative drivers of disease associations
To identify disease risk alleles influencing the expression of the distal gene(s), we investigated whether the trans-eSNPs were previously associated with complex traits or diseases. We incorporated 20,094 SNPs from the NHGRI GWAS Catalog pertaining to 1,374 disease or complex traits that were significant at a Bonferronicorrected significance threshold of P < 5 × 10 −8 . We identified 227 trans-eQTLs mapping to 29 sparse components that overlap with disease or trait-associated loci (FDR < 0.15; Supplemental Table S9 ). We used a more liberal FDR significance level (0.15) to identify trait-associated trans-eQTLs since this class of SNPs has already shown to have functional consequences. In addition, our FDR correction is applied to testing for genome-wide SNPs rather than just correcting for only the trait-associated SNPs as has been previously done 13 . Nevertheless, to ensure the robustness of the trans-eQTLs, we carried out permutation scheme and found 89 trans-eQTLs mapping to 18 components were significant at permutation threshold P < 1×10 −3 . Fig. 3A provides a subset of the trans-eQTLs that are in disease or trait-associated loci. In CG, we found 56 trans-eQTLs mapping to 14 sparse components overlapping loci associated with a disease or a complex trait at FDR < 0.15 ( Supplemental Table S10 ). Examples of colocalized trans-eQTLs with Parkinson's and Alzheimer's disease associated susceptibility loci are shown in Figure 3B . We found components that mapped to multiple independent loci and components that mapped to a single locus with multiple disease-associated variants. For example, disease-associated susceptibility alleles in the MHC class II are significantly associated with individual scores of component 363 in FF, which is active in response to all stimuli (Supplemental Fig. S3 ). The component contains several MHC class II genes but also 21 non-MHC genes (e.g., DEF8 and AOAH) with distinguishable non-zero scores. Some of the trans-associations to MHC class II alleles have been previously identified in the SNP-by-gene analysis 12 , but our analysis identified a network of 21 genes pointing to a critical biological pathway underlying disease susceptibility. We identified several other examples of trans-eQTLs in disease-associated loci (Supplemental Figs. S4-S6 ). Overall, we were able to not only reproduce previously identified trans-eQTLs and individual target genes in monocytes and macrophages but also identify biologically informative gene networks linked to distal genetic variants.
Of the disease-associated trans-eSNPs (223 in FF and 43 in CG), 85 and 27 in FF and CG, respectively, were also cis-eSNPs for nearby genes. We applied a Mendelian randomization method 34 to quantify support for a direct relationship between each SNP that has a cis-eQTL to their trans-eGene(s). We applied Mendelian randomization to test if the trans-eSNP mediated the effect on the trans-eGene(s) through their respective cis-gene using two different approaches. First, we used the individual scores from SDA for the 56 sparse components in the mediation analysis. At a nominal P < 0.05, we found 35 and 15 in FF and CG, respectively, where the cis-gene is a significant mediator of the component individual scores. In the second analysis, we directly tested for mediation using the expression level of each trans-eGene within each respective component. From this directed approach, we found a significant mediation effect for at least one trans-eGene for 79 and 21 in FF and CG trans-eSNPs, respectively. Of the significant trans mediators, we found that only 11 genes were transcription factors (TF), suggesting that TFs are not primary regulators of the trans network. However, we observed regulatory motifs for the same TF enriched among the all trans-eGenes within each network (Fig. 3C) . These include many myeloid lineage-specific factors (e.g., PU.1, C/EBPα and β, and MEF2A) and interferon-related (e.g., IRF1, IRF2, and STAT1) factors (Fig. 3C) . In summary, our results are consistent with other findings that TFs are not the primary driver of trans-eQTL networks but are enriched for specific TF binding motifs, suggesting that the trans-eGenes are under the same regulatory control.
Macrophage-specific Trans-eQTL at Parkinson's disease susceptibility loci
Considering that GWAS have identified loci with genes related to the innate immune system both in Alzheimer's disease and Parkinson's disease, we hypothesize that analysis of monocytes and macrophages could unravel new gene-sets associated with disease susceptibility. In support of this hypothesis, we observed in CG macrophages that the rs1296028 affects the expression of the lysosomal protease Cathepsin B (CTSB) (P = 1.46 x 10 -22 ; FDR = 1.31x10 -18 ) in cis (Supplemental Fig. S7 ) and the expression of 16 genes in trans (P = 8.29 x 10 -35 ; FDR = 9.48x10 -28 ) ( Figs. 4A and 4B) . The lead trans-eSNP rs1296028 (MAF = 0.11) at the CTSB locus is associated with Parkinson's disease susceptibility (in LD with GWAS lead SNP rs2740594; r 2 = 0.68) 22 . Both trans-eQTL and disease association signal were consistent with a model for shared causal variants (as indicated by coloc 35 posterior probability PP3+PP4 = 0.99, PP4/PP3 = 24) ( Fig. 3B) . Although we did not find significant enrichment of any specific biological pathways with the Ingenuity Pathway Analysis (IPA) tool, we found enrichment for biological processes such as 'lysosomal pathway' (P = 5.2x10 -3 ) and 'cholesterol degradation' (P = 6.22x10 -4 ) when we lowered the threshold for gene scores. The directions of effect for all the genes in this network were consistent: the minor allele (rs1296028-G) is associated with decreased expression of all 16 genes (Fig. 4A; Supplemental Figs. S8 and S9) . Using a small independent macrophage eQTL dataset (STARNET 5 ; n=82), we were able to replicate 4 of the 16 trans-eQTL associations (FDR < 0.20; Supplementary Fig. S10) . The direction of effect is consistent across the two datasets: rs1296028-G is associated with increased expression of the target genes as well as decreased risk for PD. Using Mendelian randomization, we found mediation effect for rs1296028 through CTSB for 11 of the genes in this network, of which the most significant mediation effects were for ANTXR1, PCDHGB4, SPAG11A and P2RY6 (Fig. 4C) . To examine the causality of this relationship between CTSB and the trans target genes, we performed siRNA-mediated knockdown of CTSB and measured the effect on the four previous mentioned genes that have β M > 1 using human THP-1 derived macrophages. We observed a concomitant reduction in ANTXR1 and PCDHGB4 mRNA levels (P < 0.05) as measured by qRT-PCR (Fig. 4D) . A non-significant effect was observed in P2RY6, whereas SPAG11A is not expressed in the THP-1 cell line. The knockdown experiment provides an independent validation for some of the genes in the CTSB trans-eQTL network. However, additional experimental validation is necessary to fully elucidate the role of CTSB lysosomal network in the etiology of Parkinson's disease.
Alzheimer's disease loci affect the expression of genes in Type 1 interferon signaling pathway
Following the same rationale, we attempted to find altered monocyte and macrophage gene networks associated with Alzheimer's disease susceptibility alleles. We found eight trans-eQTLs that overlap with Alzheimer's disease (or Alzheimer's disease-related phenotypes) susceptibility loci (Fig. 3A) , and we highlight two examples ( Figs. 5 and 6) . First, we observed that rs983392 on chromosome 11q12, reported to be associated with Alzheimer's disease (MAF = 0.41, P GWAS = 6x10 -16 ), is a trans-eQTL to a component with 54 genes of distinguishable non-zero loading scores (P = 1.5x10 -4 ; FDR < 0.15) ( Figs. 5A and 5B ). Fig. S11 ). Both trans-eQTL and disease association signal were consistent with a model for shared causal variants (as indicated by coloc 35 posterior probability PP3+PP4 = 0.93, PP4/PP3 = 4.8) (Fig. 3B) . The top-scoring genes in this component encode for Interferon-Inducible Guanylate Binding Proteins (GBP1, GBP2, GBP4, and GBP5) , followed by STAT1 and IRF1, which are key TFs for IFN-γ activation and type 1 interferon signaling ( Fig. 5B Supplemental Figs. S12-S14). The genes in this component are enriched for IPA biological processes such as 'interferon signaling' (P = 5.77x10 -16 ) and the 'antigen presentation' pathway (P = 6.62x10 -9 ). IPA also identified enrichment for several annotated biological functions including 'antiviral response' (P = 1.26x10 -33 ).
To determine if the observed trans-eQTL associations are mediated by expression of either MS4A4A or MS4A6A in cis, we performed Mendelian randomization-based mediation for using both component individual scores and gene expression levels. We observed trans-regulatory effects of rs983392 on STAT1 and SYTL3 mediated through MS4A4A but not through MS4A6A (Fig. 5C ). Another Alzheimer's disease-associated variant rs9331896-C (MAF=0.41, P GWAS = 3x10 -25 ) on located on chromosome 8p21 within intron 2 of the CLU gene is associated with the individual scores of a component consisting of 38 genes with non-zero scores (P = 1.32x10 -4 ; FDR < 0.15) ( Figs. 6A and 6B) . This component is active in IFN-γ stimulated monocytes (Fig. 6B) . Both trans-eQTL and disease association signal were consistent with a model for shared causal variants (as indicated by coloc 35 posterior probability PP3+PP4=0.96, PP4/PP3 = 47) (Fig. 3B) . The SNP rs9331896-C had no cis-eQTL effect on CLU in monocytes (or in CG macrophage) but we have reported previously a splicing QTL for CLU in DLPFC 36 and more recently we observed the same splicing event in human microglia (unpublished). Given these results, it is likely that the cis effect that we observed could mediate the trans-effect through the expression of specific isoform. The topscoring genes in the network include the members of Interferon Induced Transmembrane Proteins (IFITM1 and IFITM3) followed by MT1E, MT1X, and MT1G and OASL, all essential proteins involved in the innate immune Individual Scores B response to viral infection ( Fig. 6B; Supplemental Figs. S15-S17 ). Using IPA we found significant enrichment for 'interferon signaling' (P < 1.48x10 -8 ) and 'complement cascade' pathways (P < 2.57x10 -5 ) (Fig. 6C ). This component also contained genes in the complement components C1q family of genes (C1QA, C1QB, and C1QC). Interestingly, protein products of CLU (previously known as CLI for complement lysis inhibitor) and complement component genes physically interact and are part of a protein-protein interaction (PPI) network (Supplemental Fig. S18) , providing an independent validation of our trans-eQTL effects. Finally, we observed several genes in this component enriched for IPA biological processes such as 'Activation of Phagocytes' including AXL and TREM1 (Fig. 6C) .
To assess the robustness of the trans-eQTLs that colocalize with Alzheimer's disease risk alleles, we attempted to replicate the association signals using an independent dataset from the ImmVar study 7 . Of the 54 trans-eGenes in the MS4A4A/6A component, the expression of 10 trans-eGenes in naive monocytes were significantly associated with rs983392 (FDR < 0.20; Supplemental Fig. S19) . Many of the trans-eQTLs were highly significant in the ImmVar data including GBP2, CUL1, and SYTL3 (Fig. 5B) . Of the 38 trans-eGenes in the CLU component, expression levels of five genes were significantly associated with rs9331896 at FDR < 0.20 in the IFN stimulated monocytes (Supplemental Fig. S20 ). Despite the small size and differences in stimuli in the replication dataset, we were able to detect suggestive association signal for a small number of trans effects.
Discussion
Here, we used tensor decomposition methodology 14 to detect trans-eQTL in naïve and stimulated human monocytes and macrophages. We detected hundreds of trans-acting regulatory effects on a number of genes in sparse components. These components explain substantial amount of SNP-based genetic heritability for many common diseases. After examining the genes in each component, we observed that the target genes were involved with coherent biological processes and had regulatory motifs that are enriched for the same transcription factor. The majority of the trans-eQTLs were hotspot loci, each of which altered the expression of many genes within our sparse components. We detected significantly more trans-eQTLs in stimulated monocytes compared to naïve monocytes or macrophages despite twice the sample size for CG. Among the significant trans-eQTLs, we found 55% were stimuli-specific, suggesting that a larger number of trans-eQTLs are detectable only in the presence of specific stimuli. These observations are consistent with findings from other species such as Caenorhabditis elegans 37 and Saccharomyces cerevisiae 38 showing that environmental perturbation yields a higher number of trans-eQTLs compared to cis-eQTLs. Together, these results underscore the need to perturb primary cells with environmental stimuli to discover genotype-phenotype relationships in trans.
The target trans-eGenes reveal biological processes and downstream effects for a number of diseaseassociated susceptibility alleles. This includes Parkinson's disease associated trans-eQTLs with 16 target genes mediated by the lysosomal protease Cathepsin B (CTSB). We corroborate a previously reported cis-eQTL effect on CTSB driven by a Parkinson's disease-associated genetic variant 22, 28 . However, the main contribution of this study is our ability to detect reproducible Parkinson's disease associated trans-eQTLs and experimentally validate several of the target genes. Nevertheless, we are still unable to fully understand this gene network in the context of the disease due to our incomplete understanding of the functions of many genes within the network. The only gene in this network known have any functional interaction with CTSB to the date is ANTXR2 (same family of ANTXR1, found in the network), where CTSB -mediated autophagy flux facilitates the delivery of toxins into the cytoplasm 39 . Further functional studies will be necessary to validate not only the trans targets but also to understand mechanisms underlying the Parkinson's disease susceptibility at the CTSB locus. While alterations in autophagy and lysosomal pathways have been widely reported in neurons from Parkinson's disease 40 , our results open future mechanistic studies focusing on macrophage function and gene networks in Parkinson's disease.
We have previously reported that a number of Alzheimer's disease-associated susceptibility alleles colocalize with cis-eQTLs in peripheral monocytes 7, [41] [42] [43] . Here we hypothesized that Alzheimer's disease risk and protective alleles may modulate myeloid cell function within specific biological pathways. In support of this hypothesis, our analysis showed that the Alzheimer's disease susceptibility alleles at the MS4A4A/6A and CLU loci are associated with the individual scores of two sparse components. The component containing type 1 interferon genes explains substantial proportion (6%) of SNP-based genetic heritability for Alzheimer's disease. These trans target genes for both loci intersect with interferon-related functional genes that are responders of IFN-γ, key regulators of the IFN response (IRF1 and STAT1), and type I interferon and antiviral effectors (OAS, IFIT, and GBP families). These findings confirm previous results in the p25/Cdk5 model of neurodegeneration where a reactive microglia phenotype with activated IFN pathway was found 44 . Given that altered IFN signaling has been detected in both modules, our results suggest that dysregulation of this pathway in microglia might have a role in AD pathogenesis. The Alzheimer's disease-associated trans-eQTL in the clusterin (CLU/APOJ) locus is also associated with the expression of genes of the complement cascade. The role of the complement system in Alzheimer's disease has been suggested mostly by mouse studies in which microglia are thought to be the cellular effector of complement-mediated synaptic loss in Alzheimer's disease 45 . Indeed, C1q and oligomeric forms of amyloidβ operate in a common pathway to activate the complement cascade and drive synapse elimination by microglia 45 . In addition, a post-mortem study of Alzheimer's disease brains showed increased expression levels for complement components in the Alzheimer's disease brains 46 . Other genes in this component include marker genes (AXL and ITGAX) for damage-associated microglia, or DAM, a recently identified subset of microglia found at sites of neurodegeneration 24 . Both AXL and ITGAX are key genes involved in the Trem2-dependent DAM program, which involves upregulation of phagocytic and lipid metabolism genes 24 . The genes in the clusterin mediated network may have a role in debris clearance such as the removal of apoptotic neurons or Aβ aggregates by microglia. Further work is necessary to fully understand the role of complement and interferon signaling genes in the development and progression of AD pathology.
With this study, we demonstrate that gene expression from peripheral immune cells are a valuable source to study gene networks associated to different diseases, including neurodegenerative diseases. Nevertheless, this study has several limitations. First, while we were able to detect robust gene networks linked to distal genetic variants, we are still underpowered to detect trans target genes with smaller effect sizes. Our results suggest that many more genes have non-zero gene scores and are likely to contribute to the trans-eQTL networks but we are unable to detect them with the current sample size. We estimate that thousands of individuals would be needed to reliably detect effect sizes that explain a small proportion of the trans-QTL variance. Secondly, the reproducibility of the trans-eQTLs is still challenging without a stimulated dataset of comparable sample size. Thus, as larger datasets become available it will be important to validate our catalog of trans-eQTLs. Third, it is not clear if the trans-eQTLs networks identified in peripheral monocytes will be conserved in microglia during the transition to a reactive state under conditions of brain-tissue damage encountered during aging or neurodegeneration. These networks in monocytes may play a direct role in the pathogenesis of Alzheimer's or Parkinson's disease or, given the shared ontogeny of these two cell lineages, may serve as a proxy for microglial activities within the healthy, aged or diseased brain. While many genes are expressed in both peripheral monocytes and macrophages and CNS microglia, some of the genes are markers for microglia in the healthy brain, or are active during the transition from the homeostasis-associated state to a brain damage-response state. Future studies incorporating transcriptome profiles from primary human microglia from autopsied samples, or Induced Pluripotent Stem Cells (iPSC)-derived microglia challenged with diseaserelevant stimuli will be an important resource in uncovering trans-eQTL networks underlying neurodegenerative diseases.
In summary, we identified robust trans-eQTL networks in peripheral myeloid cells that reveal downstream biological processes of several disease-associated loci. Although further mechanistic work is necessary to validate these gene networks our findings provide compelling human genetic evidence for lysosomal pathway contributing to Parkinson's disease, and for myeloid phagocytosis, complement cascade and type I interferon-mediated signaling pathways contributing to Alzheimer's disease.
